American Pharmacy News
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • Home
  • »
  • Stories
  • »
  • American Pharmacy News Reports

Daiichi Sankyo to discontinue HER3-Lung study

American Pharmacy News Reports | Jun 1, 2016

The clinical trial evaluating patritumab as a treatment in non-small cell lung cancer will not proceed to the second part. Read More »

First Benzer Pharmacy franchise opens in Tampa

American Pharmacy News Reports | Jun 1, 2016

Kalia partners with Benzer Pharmacy to establish franchise in Tampa, Florida. Read More »

HSS provides greater transparency about health information technology

American Pharmacy News Reports | Jun 1, 2016

Upgraded website, plain language disclosures and frequent updates will help health care providers make informed decisions when purchasing health IT. Read More »

FDA grants accelerated approval for new liver disease therapy

American Pharmacy News Reports | Jun 1, 2016

Liver disease therapy Ocaliva granted accelerated approval by FDA. Read More »

Allergan and Medicines360 donate birth control devices to CDC Foundation

American Pharmacy News Reports | May 31, 2016

IUDs and oral contraceptives donated to help prevent pregnancy in areas affected by the zika virus. Read More »

CVS Pharmacy collaborates with American Diabetes Association to stop diabetes

American Pharmacy News Reports | May 31, 2016

CVS Pharmacy becomes the exclusive drugstore for the "Partner in Healthy Living" initiative. Read More »

FDA approves TEFLARO for use in pediatric patients

American Pharmacy News Reports | May 31, 2016

First branded IV antibiotic approved for use with children in more than 10 years. Read More »

New MS treatment approved by FDA

American Pharmacy News Reports | May 30, 2016

Zinbryta approved to treat relapsing forms of MS; only one monthly injection required. Read More »

NACDS announces 'Train-the-Trainer' national tour

American Pharmacy News Reports | May 30, 2016

Initial five stops on the tour announced; second consecutive summer tour to train pharmacists in point-of-care testing. Read More »

McKesson announces ideaShare conference and exhibition program

American Pharmacy News Reports | May 30, 2016

The interactive forum brings independent pharmacists together to collaborate on ways to expand business, improve profits and help their patients. Read More »

Zika prevention webinar launched by NACDS Foundation

American Pharmacy News Reports | May 30, 2016

Webinar compliments NACDS efforts in Puerto Rico to encourage women to discuss the zika virus with their health care providers and pharmacists. Read More »

Rising drug prices expected to expand exclusion lists, Tufts expert says

Kim Sunderland | May 30, 2016

Expanded exclusion lists also could impact pharmacies, patients. Read More »

FDA committee recommends diabetes treatment option for approval

American Pharmacy News Reports | May 27, 2016

Sanofi announced this week that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the Food and Drug Administration (FDA) has recommended the approval of a new drug application from the company. Read More »

CHMP offers approval recomendation for potential diabetes treatment

American Pharmacy News Reports | May 27, 2016

The Committee for Medicinal Products for Human Use (CHMP) within the European Medicines Agency has recommended the approval of saxa/dapa for use in treating type-2 diabetes. Read More »

Studies on Incyte drug to be presented at ASCO, EHA conferences

American Pharmacy News Reports | May 27, 2016

Incyte Corp. announced that approximately 20 abstracts associated with its clinical developments will be presented at the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA) meetings in 2016. Read More »

ASHP meets with White House officials on opioid addicition

American Pharmacy News Reports | May 27, 2016

The American Society of Health-System Pharmacists (ASHP) had representatives at a White House meeting regarding opioid abuse this week. Read More »

FDA approves opioid addiction medication in implant form

American Pharmacy News Reports | May 27, 2016
An example of aprescribed opioid

The U.S. Food and Drug Administration (FDA) announced that it has approved a buprenorphine implant for the treatment of opioid dependence this week. Read More »

MinuteClinic adds digital tool to cut waiting time

American Pharmacy News Reports | May 27, 2016

CVS Health announced the launch of a digital tool that will allow patients to view wait times at MinuteClinic locations, which is expected to include CVS locations in Target stores later in 2016. Read More »

Three Japanese companies to collaborate on biomarker database

American Pharmacy News Reports | May 27, 2016

The Daiichi Sankyo Co. announced this week that it will be joining Takeda Pharmaceutical Limited and Astellas Pharma Inc. in researching the development of a biomarker database. Read More »

Allergan's rosacea treatment NDA accepted by FDA

American Pharmacy News Reports | May 26, 2016

The Food and Drug Administration (FDA) has accepted a new drug application (NDA) from Allergan for a cream to treat symptoms of rosacea in adults, the company announced this week. Read More »

  • «
  • 1
  • 2
  • ...
  • 110
  • 111
  • 112 (current)
  • 113
  • 114
  • ...
  • 181
  • 182
  • »
Trending

Diana Harshbarger, U.S. Representative for Tennessee's 1st District

Rep. Harshbarger calls for PBM transparency, oversight: 'It’s time to shine a light on their shady practices'

Ted Okon, MBA, Executive Director, Community Oncology Alliance

Community Oncology Alliance Executive Director Okon on 340B: ‘Expanding participation in a flawed program isn’t reform’

Anne McDonald Pritchett, PhD, founder of Pritchett Policy Associates

Pritchett Policy Associates founder Pritchett on biosimilar access: 'PBMs are the problem not patents'

Joe Grogan, Senior Fellow at USC Schaeffer

USC Schaeffer Center Senior Fellow on 340B: 'It's malpractice for Congress having a created a program that is totally out of control to not step in a fix this'

Brian Blase, Ph.D., President of Paragon Health Institute

Paragon Health Institute links ACA and HRSA to 340B program growth, calls for reforms

Copyright © 2026 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up